Cargando…

PPARα siRNA–Treated Expression Profiles Uncover the Causal Sufficiency Network for Compound-Induced Liver Hypertrophy

Uncovering pathways underlying drug-induced toxicity is a fundamental objective in the field of toxicogenomics. Developing mechanism-based toxicity biomarkers requires the identification of such novel pathways and the order of their sufficiency in causing a phenotypic response. Genome-wide RNA inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Xudong, Souza, Angus T. De, Dai, Hongyue, Lewis, David L, Lee, Chang-kyu, Spencer, Andy G, Herweijer, Hans, Hagstrom, Jim E, Linsley, Peter S, Bassett, Douglas E, Ulrich, Roger G, He, Yudong D
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808491/ https://www.ncbi.nlm.nih.gov/pubmed/17335344 http://dx.doi.org/10.1371/journal.pcbi.0030030

Ejemplares similares

Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice
por: De Souza, Angus T., et al.
Publicado: (2006)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Zika Virus and Guillain–Barre Syndrome: Is There Sufficient Evidence for Causality?
por: Leis, A. Arturo, et al.
Publicado: (2016)

mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis
por: Selen, Ebru S., et al.
Publicado: (2021)

Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy
por: Yuan, Shuping, et al.
Publicado: (2017)

Does Sufficient Evidence Exist to Support a Causal Association between Vitamin D Status and Cardiovascular Disease Risk? An Assessment Using Hill’s Criteria for Causality
por: Weyland, Patricia G., et al.
Publicado: (2014)

Chromosome 20q Amplification Regulates in Vitro Response to Kinesin-5 Inhibitor
por: Jackson, Aimee L., et al.
Publicado: (2008)

Thyroid hormone, insulin, and glucocorticoids are sufficient to support chondrocyte differentiation to hypertrophy: a serum-free analysis
Publicado: (1992)

Effect of Berberine on PPARα/NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy
por: Wang, Mingfeng, et al.
Publicado: (2013)

Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Yu, Jing, et al.
Publicado: (2021)

Inferring causal genomic alterations in breast cancer using gene expression data
por: Tran, Linh M, et al.
Publicado: (2011)

Designing siRNA That Distinguish between Genes That Differ by a Single Nucleotide
por: Schwarz, Dianne S, et al.
Publicado: (2006)

Off-target and a portion of target-specific siRNA mediated mRNA degradation is Ago2 ‘Slicer’ independent and can be mediated by Ago1
por: Vickers, Timothy A., et al.
Publicado: (2009)

HMGB1 Is Involved in the Protective Effect of the PPARα Agonist Fenofibrate against Cardiac Hypertrophy
por: Jia, Zhankui, et al.
Publicado: (2014)

Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Liu, Zengying, et al.
Publicado: (2022)

Is there a causal link between intracellular Na elevation and metabolic remodelling in cardiac hypertrophy?
por: Aksentijevic, Dunja, et al.
Publicado: (2018)

From Sufficient Health to Sufficient Responsibility
por: Davies, Ben, et al.
Publicado: (2020)

Engineered small extracellular vesicle‑mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy
por: Kang, Ji‐Young, et al.
Publicado: (2023)

Downregulation of PTEN Promotes Autophagy via Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in PPAR α(−/−) Mice
por: Kumari, Ritu, et al.
Publicado: (2022)

Demonstration of two novel methods for predicting functional siRNA efficiency
por: Jia, Peilin, et al.
Publicado: (2006)

High Resolution Treatment Effects Estimation: Uncovering Effect Heterogeneities with the Modified Causal Forest
por: Bodory, Hugo, et al.
Publicado: (2022)

Causal model of health literacy in dietary supplement use and sufficient health behavior among working-age adults
por: Intarakamhang, Ungsinun, et al.
Publicado: (2022)

Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
por: Holmer, Magnus, et al.
Publicado: (2022)

Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
por: Sequeira, Vasco, et al.
Publicado: (2022)

PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
por: Guo, Fusheng, et al.
Publicado: (2020)

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway
por: Zhuang, Lingfang, et al.
Publicado: (2021)

TF-centered downstream gene set enrichment analysis: Inference of causal regulators by integrating TF-DNA interactions and protein post-translational modifications information
por: Liu, Qi, et al.
Publicado: (2010)

Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2021)

Is Homœopathy Sufficient in All Cases
por: Brownell, W. G.
Publicado: (1889)

Uncovering biology by single-cell proteomics
por: Mansuri, M. Shahid, et al.
Publicado: (2023)

Causal pathways to social and occupational functioning in the first episode of schizophrenia: uncovering unmet treatment needs
por: Miley, Kathleen, et al.
Publicado: (2023)

Exploring Potential Causal Genes for Uterine Leiomyomas: A Summary Data-Based Mendelian Randomization and FUMA Analysis
por: Dai, Yuxin, et al.
Publicado: (2022)

TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ Upregulation
por: Gao, Feng, et al.
Publicado: (2014)

Ligand-activated PPARδ inhibits angiotensin II-stimulated hypertrophy of vascular smooth muscle cells by targeting ROS
por: Kang, Eun Sil, et al.
Publicado: (2019)

Downregulation of PPARα during Experimental Left Ventricular Hypertrophy is Critically Dependent on Nox2 NADPH Oxidase Signalling
por: Harvey, Adam P., et al.
Publicado: (2020)

Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism
por: Zhang, Xiaoying, et al.
Publicado: (2021)

ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway
por: Cao, Yanlin, et al.
Publicado: (2023)

IKKβ Activation Is Sufficient for RANK-Independent Osteoclast Differentiation and Osteolysis
por: Otero, Jesse E, et al.
Publicado: (2010)

Sufficient Numbers of Early Germ Cells Are Essential for Female Sex Development in Zebrafish
por: Dai, Xiangyan, et al.
Publicado: (2015)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_52b7patdcc8tespk5lrmcaqblk